172 related articles for article (PubMed ID: 23856425)
1. Progress on human papillomavirus (HPV) infection and cervical cancer prevention in sub-Saharan Africa: highlights of the 27th International Papillomavirus Conference in Berlin, 17-22 September 2011.
El-Khatib Z; Tota JE; Kaufmann AM
J Epidemiol Glob Health; 2012 Jun; 2(2):99-102. PubMed ID: 23856425
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease.
Mboumba Bouassa RS; Prazuck T; Lethu T; Jenabian MA; Meye JF; Bélec L
Expert Rev Anti Infect Ther; 2017 Jun; 15(6):613-627. PubMed ID: 28440679
[TBL] [Abstract][Full Text] [Related]
3. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
[TBL] [Abstract][Full Text] [Related]
4. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer in sub-Saharan Africa: an emerging and preventable disease associated with oncogenic human papillomavirus.
Mboumba Bouassa RS; Prazuck T; Lethu T; Meye JF; Bélec L
Med Sante Trop; 2017 Feb; 27(1):16-22. PubMed ID: 28406406
[TBL] [Abstract][Full Text] [Related]
6. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.
Dzinamarira T; Moyo E; Dzobo M; Mbunge E; Murewanhema G
Int J Gynecol Cancer; 2023 Apr; 33(4):592-597. PubMed ID: 36368710
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
Ndiaye C; Alemany L; Ndiaye N; Kamaté B; Diop Y; Odida M; Banjo K; Tous S; Klaustermeier JE; Clavero O; Castellsagué X; Bosch FX; Trottier H; de Sanjosé S
Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344
[TBL] [Abstract][Full Text] [Related]
9. [The statement of Polish Gynecological Society experts about human papillomavirus (HPV) vaccine use to prevent cervical cancer (state of the art from the 19th of September 2009)].
Kotarski J; Basta A; Debski R; Karowicz-Bilińska A; Kedzia W; Niemiec T; Nowak-Markwitz E; Olejek A; Poreba R; Spaezyński M; Wysocki J;
Ginekol Pol; 2009 Nov; 80(11):870-6. PubMed ID: 20088404
[No Abstract] [Full Text] [Related]
10. The prevention of cervical cancer in Africa.
Fiander AN
Womens Health (Lond); 2011 Jan; 7(1):121-32. PubMed ID: 21175396
[TBL] [Abstract][Full Text] [Related]
11. Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination.
Ngcobo N; Jaca A; Iwu-Jaja CJ; Mavundza E
Curr Opin Immunol; 2021 Aug; 71():21-26. PubMed ID: 33857884
[TBL] [Abstract][Full Text] [Related]
12. Public health: Prevention comes of age.
Eisenstein M
Nature; 2012 Aug; 488(7413):S11-3. PubMed ID: 22932434
[No Abstract] [Full Text] [Related]
13. Reducing cervical cancer deaths in women living with HIV: PEPFAR and the Go Further partnership.
Godfrey C; Prainito A; Lapidos-Salaiz I; Barnhart M; Watts DH
Prev Med; 2021 Mar; 144():106295. PubMed ID: 33678226
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.
Louie KS; de Sanjose S; Mayaud P
Trop Med Int Health; 2009 Oct; 14(10):1287-302. PubMed ID: 19772550
[TBL] [Abstract][Full Text] [Related]
15. Model-estimated effectiveness of single dose 9-valent HPV vaccination for HIV-positive and HIV-negative females in South Africa.
Tan N; Sharma M; Winer R; Galloway D; Rees H; Barnabas RV
Vaccine; 2018 Aug; 36(32 Pt A):4830-4836. PubMed ID: 29891348
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for cervical cancer prevention in sub-saharan Africa.
Denny LA; Sankaranarayanan R; De Vuyst H; Kim JJ; Adefuye PO; Alemany L; Adewole IF; Awolude OA; Parham G; de Sanjosé S; Bosch FX
Vaccine; 2013 Dec; 31 Suppl 5():F73-4. PubMed ID: 24331750
[No Abstract] [Full Text] [Related]
17. [Expert consensus on immunological prevention of human papillomavirus-related diseases].
Vaccine and Immunization Branch, Chinese Preventive Medicine Association
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Aug; 53(8):761-803. PubMed ID: 31378039
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV) and HPV-associated tumour vaccines.
Bubeník J
Folia Biol (Praha); 2006; 52(1-2):45-6. PubMed ID: 17007109
[No Abstract] [Full Text] [Related]
19. HPV vaccination in Southern Africa: A jab of hope in the fight against cervical cancer.
Michelow P; Firnhaber C
Cancer Cytopathol; 2016 Oct; 124(10):695-698. PubMed ID: 27182785
[No Abstract] [Full Text] [Related]
20. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
Malinova M
Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
